Tech Company Financing Transactions
Prominex Funding Round
On 9/14/2018, Prominex secured $4 million in Series A funding from Casdin Capital and private investors.
Transaction Overview
Company Name
Announced On
9/14/2018
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors
private investors (Paul Thomas)
Proceeds Purpose
The Series A-1 financing will provide funding to advance the development of its infectious disease assays and commence an instrument development partnership with Invetech, a global leader in point-of-care instrument design and development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3210 Merryfield Row
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Prominex is focused on the development and manufacture of molecular diagnostic assays for Point-of-Care (POC) infectious disease testing. Our Validex System is a transformative molecular diagnostic testing solution for near patient care settings.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Thomas
Chief Operating Officer
Paul Gargan
VP - Operations
Brad Tieman
VP - Product Management
Janel Dockter
VP - R & D
Anja Bubeck-Barrett
Browse more venture capital transactions:
Prev: 9/14/2018: Shift Technologies venture capital transaction
Next: 9/14/2018: C360 Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs